Affiliation: Institute of Cancer Research, London, UK

Dr Gideon Coster obtained his BSc in Life Sciences from the Hebrew University of Jerusalem in Israel. 

He carried out his PhD research with Professor Michal Goldberg at the Genetics Department of the Hebrew University of Jerusalem. His work uncovered novel links between the DNA damage response pathway, the cell cycle machinery, and the immune response. 

Gideon then joined the lab of Dr John Diffley at the Clare Hall Laboratories of the London Research Institute, which later became part of the Francis Crick Institute, to carry out his postdoctoral work. During this time, he uncovered key mechanistic aspects of how the replicative helicase gets loaded onto DNA, work which has far-reaching implications for how our cells initiate the process of bidirectional DNA replication. 

In October 2018 Gideon joined the Cancer Biology Division of the Institute of Cancer Research (ICR) as a Group Leader, funded by a Sir Henry Dale Fellowship from the Wellcome Trust and the Royal Society. Work in his lab aims to define how difficult to replicate regions of our genome are copied accurately in healthy cells and how this goes wrong in cancer cells.